A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST)

被引：0
|
作者：
Somaiah, Neeta
Van Tine, Brian Andrew
Chmielowski, Bartosz
Drabick, Joseph J.
Chawla, Sant P.
McKean, Meredith
Spira, Alexander I.
O'Byrne, Kenneth John
Foresto, Steven A.
Movva, Sujana
Kim, AeRang
Gastman, Brian
Pressey, Joseph Gerald
Paudyal, Ben
De, Asit
Winkler, Robert E.
Li, Mingyu
Ahmad, Mohammad
Yang, Dajun
Zhai, Yifan
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Washington Univ St Louis, St Louis, MO USA
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[4] Penn State Canc Inst, Hershey, PA USA
[5] Sarcoma Oncol Res Ctr, Santa Monica, CA USA
[6] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[7] Virginia Canc Specialists, Fairfax, VA USA
[8] Princess Alexandra Hosp, Brisbane, Qld, Australia
[9] Queensland Univ Technol, Brisbane, Qld, Australia
[10] Queensland Childrens Hosp, Brisbane, Qld, Australia
[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[12] Childrens Natl Med Ctr, Washington, DC 20010 USA
[13] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[14] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[15] Ascentage Pharma Grp Inc, Rockville, MD USA
[16] Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China
[17] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14627
引用
收藏
页数：1
相关论文
共 50 条
  • [21] SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma
    Bill, Kate Lynn J.
    Garnett, Jeannine
    Meaux, Isabelle
    Ma, XiaoYen
    Creighton, Chad J.
    Bolshakov, Svetlana
    Barriere, Cedric
    Debussche, Laurent
    Lazar, Alexander J.
    Prudner, Bethany C.
    Casadei, Lucia
    Braggio, Danielle
    Lopez, Gonzalo
    Zewdu, Abbie
    Bid, Hemant
    Lev, Dina
    Pollock, Raphael E.
    CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1150 - 1160
  • [22] A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma
    Jablkowski, M
    Bocian, A
    Bialkowska, J
    Bartkowiak, J
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (01): : 117 - 125
  • [23] A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas
    Rieske, P
    Bartkowiak, JK
    Szadowska, AM
    Olborski, B
    Harezga-Bal, B
    Debiec-Rychter, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1999, 18 (03): : 403 - 416
  • [24] Phase I/II Study of A Novel MDM-2 Inhibitor (APG-115-Alrizomadlin) in p53 Wild Type Salivary Gland Cancers
    Pearson, A.
    Muzaffar, J.
    Kirtane, K.
    Bellile, E.
    Suresh, K.
    Rosenberg, A. J.
    Worden, F.
    Chung, C. H.
    Vokes, E. E.
    Brenner, C.
    McHugh, J. B.
    Zhai, Y.
    Fu, T.
    Winkler, R.
    Swiecicki, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E6 - E7
  • [25] MDM2 - master regulator of the p53 tumor suppressor protein
    Momand, J
    Wu, HH
    Dasgupta, G
    GENE, 2000, 242 (1-2) : 15 - 29
  • [26] IMMUNOHISTOCHEMICAL AND MOLECULAR ANALYSIS OF P53, MDM2, PROLIFERATING CELL NUCLEAR ANTIGEN AND KI67 IN BENIGN AND MALIGNANT PERIPHERAL-NERVE SHEATH TUMORS
    KINDBLOM, LG
    AHLDEN, M
    MEISKINDBLOM, JM
    STENMAN, G
    VIRCHOWS ARCHIV, 1995, 427 (01) : 19 - 26
  • [27] Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
    Gupta, Amit
    Shah, Karan
    Oza, Manisha J.
    Behl, Tapan
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 484 - 492
  • [28] Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    D Chen
    Z Zhang
    M Li
    W Wang
    Y Li
    E R Rayburn
    D L Hill
    H Wang
    R Zhang
    Oncogene, 2007, 26 : 5029 - 5037
  • [29] On the interaction between p53 and MDM2: Transfer NOE study of a p53-derived peptide ligated to MDM2
    Blommers, MJJ
    Fendrich, G
    GarciaEcheverria, C
    Chene, P
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (14) : 3425 - 3426
  • [30] Outcome of patients with refractory malignant peripheral nerve sheath tumors (MPNST) enrolled on phase 2 trials.
    Akshintala, Srivandana
    Mallory, Nicole C.
    Lu, Yao
    Ballman, Karla V.
    Kim, AeRang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345